Endogenous prostaglandin biosynthesis powerfully influences renal function. Our preliminary studies indicate that renal production of prostaglandins (specifically PGE2) is progressively impaired with advancing age. This deficiency may be implicated in certain disturbances in renal function associated with aging, including an impaired ability to excrete water and to stimulate the secretion of renin and aldosterone. Common disorders of the elderly (especially elderly women) such as thiazide-induced hyponatremia and hyporeninemic hypoaldosteronism might therefore be related to prostaglandin metabolism. We will test this hypothesis by studying healthy young, middle-aged and old subjects as well as infirm elderly with a history of these disorders. All studies will be carried out in women to avoid contamination of urinary prostaglandins with prostatic secretions. The response of PGE2 excretion to physiological/pharmacological stimuli such as water diuresis, dietary challenge with unsaturated fatty acids and kininase inhibition will be examined and the effects on renal function noted. Parallel studies of the inhibition of prostaglandin synthesis, using indomethacin, will also be performed. Simultaneous measurements of the plasma levels of atrial natriuretic peptide, arginine vasopressin, renin/aldosterone, and endothelin will be made in many experiments, since these factors interact in their effects on the kidney and vascular system. The results should provide information about renal prostaglandin metabolism and its relationship to renal function in the elderly, clarify the pathophysiology of electrolyte disorders to which aged patients are predisposed, and suggest approaches to their prevention and therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG000599-19
Application #
6097844
Study Section
Project Start
1996-06-01
Project End
1999-05-31
Budget Start
Budget End
Support Year
19
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Elahi, Dariush; Ruff, Dennis A; Carlson, Olga D et al. (2016) Does GLP-1 suppress its own basal secretion? Endocr Res 41:16-20
Elahi, Dariush; Angeli, Franca S; Vakilipour, Amin et al. (2014) GLP-1(32-36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs. Peptides 59:20-4
Ahmed, Sofia B; Bentley-Lewis, Rhonda; Hollenberg, Norman K et al. (2009) A comparison of prediction equations for estimating glomerular filtration rate in pregnancy. Hypertens Pregnancy 28:243-55
Abu-Hamdah, Rania; Rabiee, Atoosa; Meneilly, Graydon S et al. (2009) Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides. J Clin Endocrinol Metab 94:1843-52
Moore, T J; Rich, G; McKnight, J A et al. (1996) Salt sensitivity of hypertension and responses to angiotensin converting enzyme inhibition with benazepril. Am J Hypertens 9:54-60
Hollenberg, N K; Moore, T J (1994) Age and the renal blood supply: renal vascular responses to angiotensin converting enzyme inhibition in healthy humans. J Am Geriatr Soc 42:805-8
Allan, D R; McKnight, J A; Kifor, I et al. (1994) Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24:516-22
Bauer, K A; Kass, B L; ten Cate, H et al. (1990) Factor IX is activated in vivo by the tissue factor mechanism. Blood 76:731-6
Lee, J K; Gordon, P R; Stall, G M et al. (1989) Phenolic and tyrosyl ring iodothyronine deiodination by the Caco-2 human colon carcinoma cell line. Metabolism 38:1154-61
Bauer, K A; Weiss, L M; Sparrow, D et al. (1987) Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest 80:1527-34